Søsterhjemmet, Kirkeveien 166, 2.etasje (map)
SERAF and ProLAR have published the first scientific article that reports patient satisfaction and side effects of all three OMT medications, from a survey answered by more than 1,000 patients. ProLAR designed and implemented the survey, and SERAF helped analyze the data.
Victimization was associated with symptoms of poor mental health, more serious substance use and unstable housing.
In the 12-week, open-label, randomized-controlled study, 159 patients with opioid dependence were randomized to treatment with either extended-release naltrexone or buprenorphine-naloxone, following detoxification.
A new article from the NorComt study at SERAF examine how patients are doing one year after starting in treatment and investigate the impact of abstinent networks.
In a systematic review of all quality of life questionnaires used among opioid users in the last 25 years, researchers found out that the questionnaires were rarely adapted to this particular group.
Overdose death is the most common cause of death after release from prison among Norwegian prisoners. The increased risk of overdose death starts immediately after release.
As part of large randomized control trial of exercise within alcohol treatment in Denmark, SERAF contributed to a qualitative analysis of the reasons why some participants dropped out.
As part of the National Overdose Strategy, researchers at SERAF have developed and implemented a multi-site naloxone distribution program. There were over 2,000 naloxone nasal sprays distributed in the project’s first year and a half, with the majority of those reaching people known to be at risk of overdosing.
In collaboration with Bergen Ambulance Services, researchers at SERAF analyzed patient data for 463 overdoses from 2012 to 2013. Cases were included if the victim responded to naloxone, the opioid overdose antidote, indicating an opioid overdose.
In a survey of 2,793 young adults twins, researchers at the Norwegian Institute of Public Health in cooperation with researchers from the University of Virginia and SERAF, have investigated the heritability of cannabis abuse disorders and psychosis.
In the third article published in the NorComt study - the Norwegian cohort of patients in opioid maintenance and other drug treatment (OMT) - we administered a newly created quality of life instrument (QOL10) to a subset of patients, one year after they began outpatient OMT or inpatient treatment.
In a large national register study, SERAF-researchers investigated prescribing of benzodiazepines to more than 30,000 Danish drug users in connection with treatment admission.
SERAF has been part of a strong international research consortium that investigated the relationship between alcohol consumption and the risk for injury. Results show that the risk of experiencing injury due to violence increased with level of alcohol exposure of the victim.
In a review article in the American journal Current Opinion in Psychiatry Jørgen G. Bramness and Eline B. Rognli summarizes recent years' research literature on (meth) amphetamine and psychosis.
A study on crime among substance users was recently published from the NorCOMT-project at SERAF. More than 500 patients starting in-patient treatment or opioid maintenance treatment (OMT) were interviewed about their life situation in the last 6 months before treatment-start.
Cultural challenges are no obstacle for SERAF’s resident statistician Stefania Salvatore. The Italian Phd-candidate came to SERAF and Oslo to contribute in a large European waste water project, and has now made the Norwegian capital her home.
In a newly published SERAF-paper; “Utilizing a train-the-trainer model for multi-site naloxone distribution programs”, experiences from the Norwegian naloxone pilot program on training staff members in naloxone distribution to drug users are shared.
Eline Borger Rognli is a psychologist who has worked many years in the clinic treating patients with substance abuse problems. She is a popular speaker on topics such as the use of motivational interviewing (MI) and the treatment of patients with substance abuse and mental disorders.
At SERAF she is researching the relationship between substance abuse and psychosis. Get better acquainted with our PhD student Eline Borger Rognli.
In a new study by researchers from the Norwegian Institute of Public Health, SERAF and Hedmark University College, the results show that more young people aged 0-17 years are using psychotropic drugs than ten years ago. This is the most comprehensive overview of trends in the use of psychotropic drugs among children and young people so far made in Norway.
In a recent paper published in Quality of Life Research changes in quality of life (QoL) was investigated 6 months inpatient following detoxification treatment.
As a child she wanted to be a carpenter. Maybe that is the reason she believes a good scientist should be willing to learn from others and build on the existing knowledge, in true carpenter spirit.
Get to know our PhD student Ingeborg Skjærvø in this month’s Phd profile.
In a recently published paper in Journal of Substance Use, SERAF researchers investigated overdose deaths involving benzodiazepines and opioids (strong analgesics) in Oslo.
Different patterns of use of cannabis, cocaine, methamphetamine, heroin, ecstasy (MDMA) and ketamine was uncovered using advanced statistical methods of temporal wastewater data
The second article published by the NorComt team focuses on the quality of life of incoming patients and attempts to uncover patterns among people who seem to be struggling in particular.
As SERAF’s Danish alibi, he is investigating the use of addictive drugs in both Norway and Denmark. He is passionate about uniting the Danish field on addiction research, but he would probably also enjoy himself as team doctor for the Danish national football team. Get to know Phd-candidate Christian Tjagvad.